ArticleAntimicrobial agents and chemotherapy2026

Ceftazidime-avibactam for multidrug-resistant gram-negative infections: outcomes and timing of initiation across 22 U.S. medical centers.

Ashlan J Kunz Coyne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.